IcoSema lowers HbA1c 0.74% and weight 5.15 kg, reducing hypoglycemia vs. basal insulin.
IcoSema in Weight Management and Glycaemic Control: A Systematic Review and Meta-Analysis.
Abstract
IcoSema, a weekly insulin icodec/semaglutide combo, significantly improved HbA1c by 0.74% and reduced body weight by 5.15 kg compared to basal insulin alone in type 2 diabetes.
